Merck to Pay $688 Million to Settle Enhance Lawsuits
February 14, 2013
Christopher J. McDonald comments on the Firm's "significant recovery" for shareholders in case against Schering-Plough Corp., the largest ever in a securities class action against a drug company
Christopher McDonald, a partner at Labaton Sucharow representing Schering investors, in a telephone interview said the settlements allow a "significant recovery" for shareholders.
He said that while the federal government has been successful in pursuing large fraud cases against some pharmaceutical companies, "it hasn't translated into any significant uptick in settlements of securities cases."